Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Endocrine 1

Conditions

Neuroendocrine Tumors 13Carcinoid Tumor 5Gastro-enteropancreatic neuroendocrine tumor 4Acromegaly 4Serotonin Syndrome 2Pituitary Neoplasms 2Neoplasm Metastasis 2Prostatic Neoplasms 1Pheochromocytoma 1Peritoneal Neoplasms 1Paraganglioma 1Pancreatic Neoplasms 1Neuroendocrine Tumour With Carcinoid Symptoms 1Neuroendocrine Tumors in Lung 1Neoplasms 1Intestinal Obstruction 1Growth Hormone-Secreting Pituitary Adenoma 1Gigantism 1Gastrointestinal Neoplasms 1Flushing 1Endocrine Tumors 1Diarrhea 1Carcinoma, Merkel Cell 1Carcinoma, Hepatocellular 1Carcinoma 1Carcinoid Heart Disease 1Adenoma, Islet Cell 1

Interventions

pembrolizumab 155Gemcitabine 139Capecitabine 121Paclitaxel 118Fluorouracil 116Oxaliplatin 110Bevacizumab 104Nivolumab 97Leucovorin 97Docetaxel 92Cisplatin 89Irinotecan 87Carboplatin 84Radiosurgery 83Cyclophosphamide 70Cetuximab 70Magnetic Resonance Spectroscopy 68Trastuzumab 56Specimen Handling 56Biopsy 56Radiotherapy 55Ipilimumab 52Everolimus 48Pemetrexed 46Drug Therapy 45Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 43Doxorubicin 41Fulvestrant 38aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasm Metastasis × lanreotide × Clear all
NCT02288377 2023-01-18

REMINET

Federation Francophone de Cancerologie Digestive

Phase 2/3 Terminated
53 enrolled 11 charts
Tumor-Agnostic

Neoplasm Metastasis

NCT01731925 2017-01-31

SUNLAND

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Unknown
44 enrolled
Endocrine

Carcinoid Tumor, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡